vs

Side-by-side financial comparison of Alector, Inc. (ALEC) and TRANSACT TECHNOLOGIES INC (TACT). Click either name above to swap in a different company.

TRANSACT TECHNOLOGIES INC is the larger business by last-quarter revenue ($11.5M vs $6.2M, roughly 1.8× Alector, Inc.). On growth, TRANSACT TECHNOLOGIES INC posted the faster year-over-year revenue change (11.9% vs -88.5%). TRANSACT TECHNOLOGIES INC produced more free cash flow last quarter ($589.0K vs $-184.1M). Over the past eight quarters, TRANSACT TECHNOLOGIES INC's revenue compounded faster (3.5% CAGR vs -37.4%).

Alector, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for neurodegenerative diseases. Its product pipeline targets unmet medical needs including Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease, and it collaborates with global pharmaceutical partners to advance candidate therapies through clinical trials.

Roper Technologies, Inc. is a holding company that owns companies in the technology sector.

ALEC vs TACT — Head-to-Head

Bigger by revenue
TACT
TACT
1.8× larger
TACT
$11.5M
$6.2M
ALEC
Growing faster (revenue YoY)
TACT
TACT
+100.4% gap
TACT
11.9%
-88.5%
ALEC
More free cash flow
TACT
TACT
$184.7M more FCF
TACT
$589.0K
$-184.1M
ALEC
Faster 2-yr revenue CAGR
TACT
TACT
Annualised
TACT
3.5%
-37.4%
ALEC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALEC
ALEC
TACT
TACT
Revenue
$6.2M
$11.5M
Net Profit
Gross Margin
47.6%
Operating Margin
-10.1%
Net Margin
Revenue YoY
-88.5%
11.9%
Net Profit YoY
-1696.9%
EPS (diluted)
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALEC
ALEC
TACT
TACT
Q4 25
$6.2M
$11.5M
Q3 25
$3.3M
$13.2M
Q2 25
$7.9M
$13.8M
Q1 25
$3.7M
$13.1M
Q4 24
$54.2M
$10.2M
Q3 24
$15.3M
$10.9M
Q2 24
$15.1M
$11.6M
Q1 24
$15.9M
$10.7M
Net Profit
ALEC
ALEC
TACT
TACT
Q4 25
Q3 25
$-34.7M
$15.0K
Q2 25
$-30.5M
$-143.0K
Q1 25
$-40.5M
$19.0K
Q4 24
$-2.1M
Q3 24
$-42.2M
$-551.0K
Q2 24
$-38.7M
$-319.0K
Q1 24
$-36.1M
$-1.0M
Gross Margin
ALEC
ALEC
TACT
TACT
Q4 25
47.6%
Q3 25
49.8%
Q2 25
48.2%
Q1 25
48.7%
Q4 24
44.2%
Q3 24
48.1%
Q2 24
52.7%
Q1 24
52.6%
Operating Margin
ALEC
ALEC
TACT
TACT
Q4 25
-10.1%
Q3 25
-1153.6%
0.1%
Q2 25
-433.6%
-1.9%
Q1 25
-1216.5%
-0.1%
Q4 24
-13.4%
-10.3%
Q3 24
-315.7%
-7.7%
Q2 24
-302.4%
-3.8%
Q1 24
-275.0%
-12.2%
Net Margin
ALEC
ALEC
TACT
TACT
Q4 25
Q3 25
-1063.4%
0.1%
Q2 25
-387.7%
-1.0%
Q1 25
-1101.6%
0.1%
Q4 24
-3.8%
Q3 24
-275.2%
-5.1%
Q2 24
-256.4%
-2.8%
Q1 24
-227.0%
-9.7%
EPS (diluted)
ALEC
ALEC
TACT
TACT
Q4 25
$-0.11
Q3 25
$-0.34
$0.00
Q2 25
$-0.30
$-0.01
Q1 25
$-0.41
$0.00
Q4 24
$-0.02
$-0.80
Q3 24
$-0.43
$-0.06
Q2 24
$-0.40
$-0.03
Q1 24
$-0.38
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALEC
ALEC
TACT
TACT
Cash + ST InvestmentsLiquidity on hand
$256.0M
$20.4M
Total DebtLower is stronger
$10.0M
Stockholders' EquityBook value
$30.6M
$31.1M
Total Assets
$293.2M
$44.8M
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALEC
ALEC
TACT
TACT
Q4 25
$256.0M
$20.4M
Q3 25
$291.1M
$20.0M
Q2 25
$307.3M
$17.7M
Q1 25
$354.6M
$14.2M
Q4 24
$413.4M
$14.4M
Q3 24
$457.2M
$11.3M
Q2 24
$503.3M
$11.1M
Q1 24
$562.1M
$10.6M
Total Debt
ALEC
ALEC
TACT
TACT
Q4 25
$10.0M
Q3 25
Q2 25
Q1 25
Q4 24
$10.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ALEC
ALEC
TACT
TACT
Q4 25
$30.6M
$31.1M
Q3 25
$57.7M
$31.8M
Q2 25
$71.2M
$31.3M
Q1 25
$94.6M
$30.9M
Q4 24
$126.8M
$30.6M
Q3 24
$118.9M
$38.4M
Q2 24
$150.6M
$38.5M
Q1 24
$178.9M
$38.6M
Total Assets
ALEC
ALEC
TACT
TACT
Q4 25
$293.2M
$44.8M
Q3 25
$335.3M
$45.0M
Q2 25
$356.4M
$44.5M
Q1 25
$408.3M
$44.2M
Q4 24
$468.3M
$44.0M
Q3 24
$516.0M
$50.5M
Q2 24
$570.7M
$50.4M
Q1 24
$635.5M
$51.9M
Debt / Equity
ALEC
ALEC
TACT
TACT
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
0.08×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALEC
ALEC
TACT
TACT
Operating Cash FlowLast quarter
$-184.0M
$609.0K
Free Cash FlowOCF − Capex
$-184.1M
$589.0K
FCF MarginFCF / Revenue
-2951.3%
5.1%
Capex IntensityCapex / Revenue
0.7%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-326.5M
$7.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALEC
ALEC
TACT
TACT
Q4 25
$-184.0M
$609.0K
Q3 25
$-32.5M
$3.6M
Q2 25
$-49.0M
$3.6M
Q1 25
$-60.8M
$-161.0K
Q4 24
$-55.0M
$2.4M
Q3 24
$-50.7M
$327.0K
Q2 24
$-62.8M
$636.0K
Q1 24
$-61.3M
$-1.5M
Free Cash Flow
ALEC
ALEC
TACT
TACT
Q4 25
$-184.1M
$589.0K
Q3 25
$-32.5M
$3.6M
Q2 25
$-49.1M
$3.6M
Q1 25
$-60.8M
$-171.0K
Q4 24
$-55.2M
$2.4M
Q3 24
$-50.9M
$259.0K
Q2 24
$-63.1M
$499.0K
Q1 24
$-61.9M
$-1.6M
FCF Margin
ALEC
ALEC
TACT
TACT
Q4 25
-2951.3%
5.1%
Q3 25
-997.6%
27.1%
Q2 25
-623.0%
25.9%
Q1 25
-1655.0%
-1.3%
Q4 24
-101.8%
23.2%
Q3 24
-332.1%
2.4%
Q2 24
-418.6%
4.3%
Q1 24
-389.3%
-14.9%
Capex Intensity
ALEC
ALEC
TACT
TACT
Q4 25
0.7%
0.2%
Q3 25
0.3%
0.5%
Q2 25
0.1%
0.1%
Q1 25
0.5%
0.1%
Q4 24
0.3%
0.1%
Q3 24
1.4%
0.6%
Q2 24
2.2%
1.2%
Q1 24
3.4%
1.0%
Cash Conversion
ALEC
ALEC
TACT
TACT
Q4 25
Q3 25
242.00×
Q2 25
Q1 25
-8.47×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons